As Erie Indty Co (ERIE) Shares Rose, Blackrock Decreased Its Holding by $709,676; Kahn Brothers Group Holds Holding in Glaxosmithkline (GSK)

GlaxoSmithKline plc (NYSE:GSK) Logo

Blackrock Inc decreased its stake in Erie Indty Co (ERIE) by 0.58% based on its latest 2018Q3 regulatory filing with the SEC. Blackrock Inc sold 5,588 shares as the company’s stock rose 3.46% while stock markets declined. The institutional investor held 955,148 shares of the specialty insurers company at the end of 2018Q3, valued at $121.81M, down from 960,736 at the end of the previous reported quarter. Blackrock Inc who had been investing in Erie Indty Co for a number of months, seems to be less bullish one the $8.25B market cap company. The stock decreased 0.58% or $0.92 during the last trading session, reaching $157.81. About 30,296 shares traded. Erie Indemnity Company (NASDAQ:ERIE) has risen 8.47% since February 11, 2018 and is uptrending. It has outperformed by 8.47% the S&P500. Some Historical ERIE News: 25/05/2018 – Erie Insurance names Kepperling as Illinois branch manager; 11/05/2018 – Erie Insurance names Carlin to leadership role; 27/04/2018 – Erie Insurance Earns Highest Ranking in J.D. Power Insurance Shopping Study; 03/05/2018 – New Research Coverage Highlights Erie Indemnity, Merit Medical, Destination Maternity, Perry Ellis International, Tower Interna; 25/04/2018 – Can in-car conversations actually make driving safer?; 26/04/2018 – Erie Indemnity 1Q Net $65.8M; 03/05/2018 – Erie Insurance names Gustafson to vice president role; 26/04/2018 – Erie Indemnity 1Q Rev $572.2M; 18/05/2018 – Erie Insurance names Palczer to claims vice president role; 26/03/2018 Seven Things to Know Before Signing a Lease

Kahn Brothers Group Inc increased its stake in Glaxosmithkline (GSK) by 0.4% based on its latest 2018Q3 regulatory filing with the SEC. Kahn Brothers Group Inc bought 4,924 shares as the company’s stock declined 4.12% with the market. The hedge fund held 1.24 million shares of the major pharmaceuticals company at the end of 2018Q3, valued at $49.87 billion, up from 1.24M at the end of the previous reported quarter. Kahn Brothers Group Inc who had been investing in Glaxosmithkline for a number of months, seems to be bullish on the $98.19B market cap company. The stock decreased 1.96% or $0.81 during the last trading session, reaching $40.28. About 4.65M shares traded or 24.00% up from the average. GlaxoSmithKline plc (NYSE:GSK) has risen 8.15% since February 11, 2018 and is uptrending. It has outperformed by 8.15% the S&P500. Some Historical GSK News: 27/03/2018 – Novartis sells stake in venture to GSK for $13 bln; 23/04/2018 – QUEBEC’S CIQ RECOMMENDS PREFERENTIAL USE OF SHINGRIX; 18/04/2018 – GSK: FURTHER SUBMISSIONS IN OTHER COUNTRIES EXPECTED IN 2018; 09/04/2018 – Novartis shells out $8.7 bln to buy AveXis; 18/05/2018 – EU warns of possible birth defect link to GSK’s HIV drug; 12/04/2018 – GSK sells rare disease gene therapy portfolio; 09/05/2018 – GlaxoSmithKline CFO to Retire in May 2019; 25/04/2018 – GlaxoSmithKline Declares Dividend of 19p; 25/04/2018 – Currency and pricing squeeze GlaxoSmithKline as new shingles vaccine shines; 11/05/2018 – GSK CONSUMER 4Q OTHER INCOME 841.7M RUPEES

More notable recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Seekingalpha.com which released: “Glaxo chairman to step down – Seeking Alpha” on January 22, 2019, also Seekingalpha.com with their article: “Merck KGaA teams up with Glaxo to develop cancer candidate – Seeking Alpha” published on February 05, 2019, Seekingalpha.com published: “Data analysis shows superiority of Glaxo’s Nucala in patients with severe asthma – Seeking Alpha” on September 10, 2018. More interesting news about GlaxoSmithKline plc (NYSE:GSK) were released by: Seekingalpha.com and their article: “GlaxoSmithKline 2018 Q3 – Results – Earnings Call Slides – Seeking Alpha” published on October 31, 2018 as well as Seekingalpha.com‘s news article titled: “GlaxoSmithKline: Watching Dividend Trends Closely – Seeking Alpha” with publication date: January 26, 2019.

Kahn Brothers Group Inc, which manages about $651.15B US Long portfolio, decreased its stake in Mbia (NYSE:MBI) by 62,450 shares to 4.55M shares, valued at $48.66 billion in 2018Q3, according to the filing. It also reduced its holding in Patterson Energy (NASDAQ:PTEN) by 15,900 shares in the quarter, leaving it with 1.37M shares, and cut its stake in Rafael Holding.

Among 19 analysts covering GlaxoSmithKline (NYSE:GSK), 7 have Buy rating, 1 Sell and 11 Hold. Therefore 37% are positive. GlaxoSmithKline had 35 analyst reports since September 8, 2015 according to SRatingsIntel. The rating was downgraded by Barclays Capital to “Equal-Weight” on Thursday, December 6. Argus Research maintained the stock with “Buy” rating in Monday, December 7 report. The firm earned “Underweight” rating on Friday, September 8 by Morgan Stanley. The firm has “Buy” rating given on Friday, May 26 by Berenberg. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Neutral” rating by JP Morgan on Monday, October 12. The rating was upgraded by BNP Paribas on Tuesday, September 15 to “Neutral”. Cowen & Co maintained GlaxoSmithKline plc (NYSE:GSK) rating on Monday, December 11. Cowen & Co has “Hold” rating and $38.0 target. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Overweight” rating given on Friday, September 23 by Piperjaffray. Bryan Garnier & Cie upgraded the shares of GSK in report on Wednesday, January 27 to “Buy” rating. Cowen & Co maintained the stock with “Hold” rating in Wednesday, February 14 report.

Since August 21, 2018, it had 4 buys, and 0 insider sales for $359,552 activity. Colaizzo Louis F had bought 750 shares worth $99,750 on Monday, December 31. NECASTRO TIMOTHY G had bought 160 shares worth $20,994.

More notable recent Erie Indemnity Company (NASDAQ:ERIE) news were published by: Fool.com which released: “Why Churchill Downs Stock Gained 13% in January – Motley Fool” on February 07, 2019, also Marketwatch.com with their article: “Trump says the Fed has ‘gone crazy’ after the Dow tumbles 830 points in one day – MarketWatch” published on October 11, 2018, Bizjournals.com published: “Churchill Downs completes $179 million casino purchase – Louisville Business First” on January 14, 2019. More interesting news about Erie Indemnity Company (NASDAQ:ERIE) were released by: Nasdaq.com and their article: “Q2 Earnings Season Showing Strong Revenue Momentum – Nasdaq” published on July 20, 2018 as well as Nasdaq.com‘s news article titled: “CNB Financial Corporation Reports Record Year End 2018 Earnings, Highlighted by Strong Organic Loan and Deposit Growth – Nasdaq” with publication date: January 28, 2019.

Blackrock Inc, which manages about $2311.12B US Long portfolio, upped its stake in O Reilly Automotive Inc New (NASDAQ:ORLY) by 75,454 shares to 6.04M shares, valued at $2.10 billion in 2018Q3, according to the filing. It also increased its holding in Inphi Corp (NYSE:IPHI) by 41,569 shares in the quarter, for a total of 2.90M shares, and has risen its stake in Otter Tail Corp (NASDAQ:OTTR).

Erie Indemnity Company (NASDAQ:ERIE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.